Literature DB >> 6083971

Sialomucins and carcinoembryonic antigen in the evolution of colorectal cancer.

P Greaves, M I Filipe, S Abbas, M G Ormerod.   

Abstract

We have explored the merit of a simultaneous study of sialomucin content and carcinoembryonic antigen (CEA) expression in the identification of early malignancy in adenomas. One hundred and thirteen colorectal adenomas were investigated by histochemical and immunocytochemical techniques. We compared adenomas from 'high risk' patients having synchronous carcinoma and 'low risk' groups with incidental polyps only. Twenty-three metaplastic and eight inflammatory polyps were also included. Our data suggest that size and dysplasia are not always closely related and that synchronous adenomas seem to carry a higher malignant potential than incidental polyps irrespective of size. The degree of O-acylation of sialic acids appears to be a sensitive indicator of early malignant change: loss of O-acylation was seen in all II adenomas with highly atypical foci ('focal carcinoma') but noted in only four of the remaining polyps with lower grade dysplasia (P less than 0.005). By contrast the intensity of staining for CEA was a gradual phenomenon and showed no statistically significant increase with the onset of malignancy. Inflammatory polyps showed staining characteristics similar to normal mucosa. Metaplastic polyps, however, revealed increased expression of CEA and reduced O-acylation with increased size which may reflect a disorder of growth and differentiation. Finally, by comparing these profiles of staining with those of normal mucosa, 'transitional' mucosa adjacent to carcinoma and carcinoma, we further illustrate a progression of changes occurring in colonic mucosa in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6083971     DOI: 10.1111/j.1365-2559.1984.tb02398.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

Review 1.  Mucin histochemistry in colorectal disease: principles and potential clinical applications.

Authors:  W V Bogomoletz
Journal:  Int J Colorectal Dis       Date:  1986-10       Impact factor: 2.571

2.  Histochemical procedures for the simultaneous visualization of neutral sugars and either sialic acid and its side chain O-acyl variants or O-sulphate ester. I. Methods based upon the selective periodate oxidation of sialic acids.

Authors:  D Volz; P E Reid; C M Park; D A Owen; W L Dunn
Journal:  Histochem J       Date:  1987-05

3.  Sialic acid histochemistry and the adenoma-carcinoma sequence in colorectum.

Authors:  S Agawa; J R Jass
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

4.  Observer reproducibility in grading dysplasia in colorectal adenomas: comparison between two different grading systems.

Authors:  C Fenger; M Bak; O Kronborg; H Svanholm
Journal:  J Clin Pathol       Date:  1990-04       Impact factor: 3.411

5.  Spectrum of carcinoembryonic antigen immunoreactivity from isolated ductal hyperplasias to atypical hyperplasias associated with infiltrating ductal breast cancer.

Authors:  F C Schmitt; L Andrade
Journal:  J Clin Pathol       Date:  1995-01       Impact factor: 3.411

6.  Colorectal goblet cell sialomucin heterogeneity: its relation to malignant disease.

Authors:  K Sugihara; J R Jass
Journal:  J Clin Pathol       Date:  1986-10       Impact factor: 3.411

Review 7.  The clinical and biological significance of the transitional mucosa adjacent to colorectal cancer.

Authors:  Q A Wang; H Gao; Y H Wang; Y L Chen
Journal:  Jpn J Surg       Date:  1991-05

8.  Value of mucin histochemistry in follow up surveillance of patients with long standing ulcerative colitis.

Authors:  J R Jass; J England; K Miller
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

9.  The adenoma-carcinoma sequence in the colorectum--early appearance of a hierarchy of small intestinal mucin antigen (SIMA) epitopes and correlation with malignant potential.

Authors:  S J Pilbrow; P J Hertzog; A W Linnane
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.